Abstract
Heterocyclic 1,2,4-triazoles and their derivatives, such as triazolopyridines, have been used as leading components for the synthesis of numerous heterocyclic compounds; and because of their various biological activities, they have a distinct location in pharmaceutical and medicinal chemistry. In this article, we demonstrate a new way of synthesizing 1,2,4-triazolo[1,5-a]pyridine derivatives, as a one-pot pseudo-three-component reaction, via the reaction of pyridine-2-(1H)-one derivatives and 1,4-cyclohexadione in the adjacency of acetic acid both as solvent and an inexpensive and green catalyst at 50 °C. The desired products were synthesized in good yields, and the chemical structure of the synthesized compounds was recognized using 1H and 13C NMR spectra, FT-IR, melting point, mass spectroscopy, and elementary analysis.
Graphic abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Multi-component reactions (MCRs) have appeared as highly impressive instrumentation in modern synthetic organic chemistry due to properties such as atom economy, direct and straight reaction design, and the opportunity to manufacture target organic molecules by presenting various elements. Typically, purification of products resulting from MCRs is also reasonably modest since all the occupied reactants are used and are synthesized into the target compound [1,2,3,4,5,6,7,8,9,10]. MCRs leading to interesting heterocyclic compounds are individually crucial for the preparation of diverse chemical libraries of drug-like molecules [11].
Heterocyclic chemistry is a highly competing and amply rewarding field, and by far, heterocycles form the largest class in organic chemistry. The majority of biologically active agrochemicals, pharmaceuticals, modifiers, and additives used in industrial usages are heterocyclic by nature [12]. Synthetic organic chemists have made remarkable progress in detecting and developing a vast range of heterocyclic compounds human benefits. Among the heterocyclic compounds, pyridines and triazoles are among the key heterocycles exhibiting significant pharmacological activity as they are fundamental constituents of all cells and living matter [13, 14]. Triazole is a five-membered heterocyclic ring, which contains three nitrogen atoms 1, 2, and 4 locations. Several methods have previously been related to triazolo[1,5-a]pyridines production from pyridines [15,16,17,18], especially 1,6-diaminopyridines [19,20,21,22,23]. As heterocyclic components, triazolopyridines have been applied in the construction of pharmaceutical ingredients with diverse biological effects [24,25,26,27], including antiproliferative, anti-inflammatory, and antithrombotic agents. Triazolopyridines act as inhibitors at growth hormone secretagogs [28] or mitogen-activated protein (MAP) kinases [29, 30]. They are also used to treat antithrombotic agents [31] and gastrointestinal disorders [32]. Therefore, various suitable methods are of remarkable interest for their synthesis. 1,2,4-Triazole-based compounds exhibit vastly potential usages in supramolecular, medicinal, chemical, agricultural, as well as material sciences [33, 34]. In medicinal chemistry, the unique structure of triazole ring made its derivatives easily fasten with a diversity of enzymes and receivers such as antioxidants, anticoagulants, anticancer, as well as antifungal, antiviral, antibacterial, and anti-inflammatory agents in biological activities [35,36,37].
Results and discussion
The enormous biological and pharmacological importance of triazolopyridine derivatives encouraged us to design a modern and effective protocol for their synthesis. In this scope, being commercially available, economically cost-effective, and environmentally friendly, acetic acid could be used as an essential, efficient, and green catalyst in the synthesis of novel 1,2,4-triazolo[1,5-a]pyridine derivatives. In our experiment for the integration of 1,2,4-triazolo[1,5-a]pyridines, we performed the reaction between 1,6-diaminopyridines 1 (2 mmol) and 1,4-cyclohexadione (2, 1 mmol) in the adjacency of heated acetic acid at 50 °C (Scheme 1). The reaction was carried out in different conditions and the best result was obtained for acetic acid as both solvent and an inexpensive and green catalyst at 50 °C (Table 1, entry 7). The separated product 7,7,7″,7″-tetramethyl-5,5″-dioxo-1,1″,5,5″,6,6″,7,7″-octahydro-3H,3″H-dispiro[[1,2,4]triazolo[1,5-a]pyridine-2,1′-cyclohexane-4′,2″-[1,2,4]triazolo[1,5-a]pyridine]-6,6″,8,8″-tetracarbonitrile (3a) was fully described based on FT-IR, 1H, 13C NMR, and MS spectroscopy and elemental analysis. In the 1H NMR spectra, the four protons at NH of triazole rings display two singlets at 6.36, 6.39 and two singlets at 8.70, 8.73 ppm; moreover, two protons at CH of pyridine rings display two singlets at 4.59, 4.61 ppm, and the presence of this number of peaks in these areas indicates the reaction of two components of 1,6-diaminopyridine with 1,4-cyclohexadione (see experimental section). To study the possibility of this work, diversity of pyridine-2(1H)-one derivatives synthesis by a reported manner [38] reacted with 1,4-cyclohexadione under reaction conditions and led to final products in acceptable yields (Table 2).
The proposed mechanism for the acid-catalyzed reaction between 1,4-cyclohexadione and pyridine-2-(1H)-one derivatives is depicted in Scheme 2. Initially, the active group of amine that bonded to the N atom of the pyridine ring attacks the carbonyl group and immediately other amine group attacks the same carbon after aqueous distillation by acetic acid as catalyst, leading to the production of 1,2,4-triazole biologically active heterocyclic helper headings, and then the same happens to the other carbonyl group in 1,4-cyclohexadione.
Conclusion
In conclusion, in a novel and efficient approach, we characterized and synthesized 1,2,4-triazolo[1,5-a]pyridine derivatives as new spiro biologically active compounds with the reaction of pyridine-2(1H)-one derivatives with 1,4-cyclohexadione compounds and by applying acetic acid both as solvent and a green catalyst. This method offers several benefits including green conditions, short reaction times, mild reaction conditions, excellent yields, and a simple workup procedure, but no need for column chromatography. Via its Brϕnsted acid nature, acetic acid advances reactions by being involved in nucleophilic addition as well as dehydration steps.
Experimental
Melting points of all compounds were measured with an Electrothermal 9100 apparatus. All of the reagents were purchased from Fluka, Merck, and Aldrich companies, and were used without further purification. In addition, the 1H NMR and 13C NMR spectra were recorded on a Bruker Avance DPX-300 instrument using DMSO-d6 as an internal standard at 300 and 75 MHz, respectively. FT-IR spectra of all compounds were measured with a JASCO FT-IR-460 plus spectrometer. Elemental analyses for C, H, and N, and mass spectra were recorded using a Heraeus CHN–O-Rapid analyzer and on an Agilent Technology (HP) 5973 mass spectrometer operating at an ionization potential of 70 eV, respectively.
General procedure for the synthesis of compound 3
Initially, pyridine-2-(1H)-one derivatives 1 were prepared by a reported process [38]. Then, a mixture of pyridine-2-(1H)-one derivatives 1 (2.0 mmol) and 1,4-cyclohexadione (2, 1.0 mmol) in 2.0 cm3 acetic acid was located in a 5.0 cm3 round-bottomed flask mounted over a magnetic stirrer. The contents in an oil bath maintained at 50 °C for an adequate time were stirred magnetically as shown in Table 2. The reaction time was monitored by TLC; after the reaction was complete, the reaction mixture was allowed to cool at room temperature. Then, the solid was obtained smooth, and the reliable product was separated. The separated product was washed twice with water (2 × 10 cm3) to afford pure products. The spectral and analytical data of all the compounds are given below.
7,7,7″,7″-Tetramethyl-5,5″-dioxo-1,1″,5,5″,6,6″,7,7″-octahydro-3H,3″H-dispiro[[1,2,4]triazolo[1,5-a]pyridine-2,1′-cyclohexane-4′,2″-[1,2,4]triazolo[1,5-a]pyridine]-6, 6″,8,8″-tetra-carbonitrile (3a, C24H26N10O2)
Green-blue solid; yield 90%; m.p.: 287–289 °C; 1H NMR (DMSO-d6, 300 MHz): δ = 8.73 (s, NH, 1H), 8.70 (s, NH, 1H), 6.39 (s, NH, 1H), 6.36 (s, NH, 1H), 4.61 (s, CH, 1H), 4.59 (s, CH, 1H), 1.93–1.66 (m, 4CH2, 8H), 1.31 (s, 2CH3, 6H), 1.17 (s, 2CH3, 6H) ppm; 13C NMR (DMSO-d6, 75 MHz): δ = 21.53, 24.70, 26.78, 30.80, 31.20, 31.41, 35.61, 48.23, 59.98, 60.05, 77.57, 115.83, 118.78, 118.80, 151.10, 151.42, 157.94, 158.10 ppm; FT-IR (KBr): \( \bar{v} \) = 3368, 3229, 2928, 2864, 2184, 1711, 1651, 1395, 1099 cm−1; MS (EI, 70 eV): m/z (%) = 485 (M+, 31).
7,7″-Dicyclopropyl-7,7″-dimethyl-5,5″-dioxo-1,1″,5,5″,6,6″,7,7″-octahydro-3H,3″H-dispiro[[1,2,4]triazolo[1,5-a]pyridine-2,1′-cyclohexane-4′,2″-[1,2,4]triazolo[1,5-a]pyridine]-6,6″,8,8″-tetracarbonitrile (3b, C28H30N10O2)
Green-blue solid; yield 85%; m.p.: 285–288 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.61 (s, 1H, NH), 8.56 (s, 1H, NH), 6.35 (s, 1H, NH), 6.32 (s, 1H, NH), 4.61 (s, 1H, CH), 4.59 (s, 1H, CH), 1.78–1.46 (m, 8H, 4CH2), 1.21 (s, 6H, 2 CH3), 0.81–0.79 (m, 2H, 2CH), 0.28–0.25 (m, 4H, 2CH2), 0.00 to − 0.06 (m, 4H, 2CH2) ppm; 13C NMR (75 MHz, DMSO-d6): δ = − 1.51 (CH2 cyclopropyl), − 0.50 (CH2 cyclopropyl), 15.31 (CH cyclopropyl), 15.36 (CH3), 23.44, 23.61, 28.37, 28.46, 29.31, 29.38, 36.41, 36.43, 46.57, 51.44, 51.47, 75.49, 75.52, 113.79, 117.60, 117.62, 150.08, 150.15, 156.17, 156.19 ppm; IR (KBr): \( \bar{v} \) = 3362, 3238, 2935, 2862, 2191, 1716, 1651, 1411 cm−1; MS (EI, 70 eV): m/z (%) = 537 ([M-1]+, 100).
5′,5‴-Dioxo-5′,5‴,6′,6‴-tetrahydro-1′H,1‴H,3′H,3‴H-tetraspiro[cyclopentane-1,7′-[1,2,4]triazolo[1,5-a]pyridine-2′,1″-cyclohexane-4″,2‴-[1,2,4]triazolo[1,5-a]pyridine-7‴,1′′′′-cyclopentane]-6′,6‴,8′,8‴-tetracarbonitrile (3c, C28H30N10O2)
Green-blue solid; yield 80%; m.p.: 267–269 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.76 (s, 1H, NH), 8.75 (s, 1H, NH), 6.36 (s, 2H, 2NH), 4.66 (s, 1H, CH), 4.64 (s, 1H, CH), 2.10–1.62 (m, 24H, 12CH2) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 24.44, 24.60, 30.92, 31.13, 31.25, 36.54, 36.60, 37.17, 45.79, 46.30, 46.34, 60.02, 77.77, 116.33, 119.41, 119.44, 151.52, 158.69, 158.73 ppm; IR (KBr): \( \bar{v} \) = 451, 3329, 2928, 2800, 2251, 2180, 1702, 1645, 1415, 1104 cm−1; MS (EI, 70 eV): m/z = 538.
5′,5‴-Dioxo-5′,5‴,6′,6‴-tetrahydro-1′H,1‴H,3′H,3‴H-tetraspiro[cyclohexane-1,7′-[1,2,4]triazolo[1,5-a]pyridine-2′,1″-cyclohexane-4″,2‴-[1,2,4]triazolo[1,5-a]pyridine-7‴,1′′′′-cyclohexane]-6′,6‴,8′,8‴-tetracarbonitrile (3d, C30H34N10O2)
Green-blue solid; yield 95%; m.p.: 286–288 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.79 (s, 1H, NH), 8.78 (s, 1H, NH), 6.36 (s, 1H, NH), 6.35 (s, 1H, NH), 4.54 (s, 1H, CH), 4.52 (s, 1H, CH), 1.93–1.31 (m, 28H, 14CH2) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 21.52, 21.68, 25.26, 31.00, 31.10, 33.37, 34.18, 38.24, 38.26, 46.45, 46.86, 58.18, 58.31, 77.63, 116.06, 120.15, 120.25, 152.22, 152.28, 158.06, 158.18 ppm; IR (KBr): \( \bar{v} \) = 3368, 3208, 2931, 2858, 2175, 1703, 1639, 1413, 1106 cm−1; MS (EI, 70 eV): m/z = 565.
4,4′′′′-Dimethyl-5′,5‴-dioxo-5′,5‴,6′,6‴-tetrahydro-1′H,1‴H,3′H,3‴H-tetraspiro[cyclohexane-1,7′-[1,2,4]triazolo[1,5-a]pyridine-2′,1″-cyclohexane-4″,2‴-[1,2,4]triazolo[1,5-a]pyridine-7‴,1′′′′-cyclohexane]-6′,6‴,8′,8‴-tetracarbonitrile (3e, C32H38N10O2)
Green-blue solid; yield 82%; m.p.: 289–290 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.82 (s, 1H, NH), 8.80 (s, 1H, NH), 6.35 (s, 2H, 2NH), 4.58 (s, 1H, CH), 4.56 (s, 1H, CH), 1.83–1.66 (m, 26H, 2CH, 12CH2), 0.96 (d, J = 3 Hz, 6H, 2CH3) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 22.51, 30.51, 30.80, 31.09, 31.19, 31.57, 32.94, 34.09, 37.74, 49.10, 49.13, 56.98, 57.03, 77.70, 115.92, 120.84, 120.86, 152.70, 158.77, 158.79 ppm; IR (KBr): \( \bar{v} \) = 3361, 3202, 2925, 2856, 2176, 1702, 1641, 1415, 1109 cm−1; MS (EI, 70 eV): m/z = 593.
5′,5‴-Dioxo-5′,5‴,6′,6‴-tetrahydro-1′H,1‴H,3′H,3‴H-tetraspiro[cycloheptane-1,7′-[1,2,4]triazolo[1,5-a]pyridine-2′,1″-cyclohexane-4″,2‴-[1,2,4]triazolo[1,5-a]pyridine-7‴,1′′′′-cycloheptane]-6′,6‴,8′,8‴-tetracarbonitrile (3f, C32H38N10O2)
Green–blue solid; yield 87%; m.p.: 266–267 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.72 (s, 2H, 2NH), 6.37 (s, 2H, 2NH), 4.49 (s, 1H, CH), 4.47 (s, 1H, CH), 1.93–1.45 (m, 32H, 16CH2) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 21.51, 22.68, 23.10, 30.10, 30.38, 30.99, 35.87, 38.66, 41.39, 48.20, 60.59, 77.60, 116.45, 120.09, 120.13, 151.66, 158.12, 158.17 ppm; IR (KBr): \( \bar{v} \) = 3451, 3329, 2928, 2800, 2251, 2180, 1702, 1645, 1415, 1104 cm−1; MS (EI, 70 eV): m/z = 593.
5′,5‴-Dioxo-5′,5‴,6′,6‴-tetrahydro-1′H,1‴H,3′H,3‴H-tetraspiro[cyclododecane-1,7′-[1,2,4]triazolo[1,5-a]pyridine-2′,1″-cyclohexane-4″,2‴-[1,2,4]triazolo[1,5-a]pyridine-7‴,1′′′′-cyclododecane]-6′,6‴,8′,8‴-tetracarbonitrile (3g, C42H58N10O2)
Green solid; yield 93%; m.p.: 250–252 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.99 (s, 1H, NH), 8.74 (s, 1H, NH), 6.62 (s, H, NH), 6.41(s, 1H, NH), 4.20 (s, 1H, CH), 4.14 (s, 1H, CH), 1.93–1.36 (m, 52H, 26CH2) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 19.94, 21.51, 21.94, 22.11, 22.20, 22.46, 26.00, 26.28, 26.40, 30.73, 30.79, 31.40, 31.56, 32.01, 44.48, 44.49, 57.80, 58.37, 77.45, 116.04, 119.64, 119.69, 150.92, 151.20, 57.12, 157.41 ppm; IR (KBr): \( \bar{v} \) = 3362, 3238, 2935, 2862, 2191, 1716, 1651, 1411 cm−1; MS (EI, 70 eV): m/z = 734.
References
Ghahremanzadeh R, ImaniShakibaei G, Ahadi S, Bazgir A (2010) J Comb Chem 12:191
Ramazani A, Nasrabadi FZ, Karima Z, Rouhani M (2011) Bull Korean Chem Soc 32:2700
Adrom B, Hazeri N, Lashkari M, Maghsoodlou MT (2016) J Chem Res 40:458
Mousavi MR, Maghsoodlou MT, Hazeri N, Habibi-Khorassani SM (2015) J Iran Chem Soc 12:1419
Sajadikhah SS, Maghsoodlou MT, Hazeri N, Mohamadian-Souri S (2016) Res Chem Intermed 42:2805
Kangani M, Hazeri N, Yazdani-Elah-Abadi A, Maghsoodlou MT (2017) J Chin Chem Soc 64:481
Mousavi MR, Maghsoodlou MT (2014) Monatsh Chem 145:1967
Aelami Z, Maghsoodlou MT, Hydari R (2019) Chem Sel 4:5315
Kangani M, Hazeri N, Maghsoodlou MT (2016) J Chin Chem Soc 63:896
Safarzaei M, Maghsoodlou MT, Mollashahi E, Hazeri N, Lashkari M (2018) Res Chem Intermed 44:7449
Rmazani A, Kazemizadeh AR (2011) Curr Org Chem 15:3986
Katritzky AR, Ress CW, Scriven EFV (1996) Comprehensive heterocyclic chemistry II. Pergamon Press, Oxford
Katritzky AR, Ramsden CA, Scriven EFV, Taylor RJK (2008) Comprehensive heterocyclic chemistry III. Pergamon Press, Oxford
Al-Soud Y, Al-Dweri M, Al-Masoudi N (2004) Il Farmaco 59:775
Abarca B, Aucejo R, Ballesteros R, Blanco F, Garica-Espana E (2008) Tetrahedron Lett 47:8101
Abadi A, Al-Deeb O, Al-Afify A, El-Kashef H (1999) Il Farmaco 54:195
Dube D, Brideau C, Deschenes D, Fortin R, Friesen RW, Gordon R, Girard Y, Riendeau D, Savoie C, Chan CC (1999) Bioorg Med Chem Lett 9:1715
Mostafa Hussein AH (1997) Heteroat Chem 8:1
Harb AA (2004) Chem Pap 58:260
Al-Omran F, Abdel Khalik MM, Elnagdi MH (1995) Heteroat Chem 6:545
Yamada Y, Yasuda H, Takayama A (1998) Heterocycles 48:1185
Phadak RC, Rangnekar DW (1986) Synthesis 860
Lin YI, Lang SA (1981) J Org Chem 46:3123
Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA (2006) Biopharm Drug Dispos 27:371
Luethy C, Hall RG, Edmunds A, Riley S, Diggelmann M (2008) Preparation of triazolopyridines as herbicides. PCT Int Appl WO 2008006540. Chem Abstr 148:168724
Abel U, Depp H, Feurer A, Gradler U, Ott I, Matassa VG (2006) Preparation of [1,2,4]triazolo[4,3-a]pyridine derivatives for treatment of hyperproliferative diseases. PTC Int Appl WO 06058752. Chem Abstr 145:46065
Reichelt A, Falsey JR, Rzasa RM, Oliver RT, Achmatowicz MM, Larsen RD, Zhang D (2010) Org Lett 12:792
Jarome KD, Rucker PV, Xing L, Shieh HS, Baldus JE, Selness SR, Letavic MA, Braganza JF, McClure KF (2010) Bioorg Med Chem Lett 20:469
Foster ML, Halley F, Souness JE (2000) Drug News Perspect 13:488
Yu G, Li J, Ewing WR, Sulsky RB, Li JJ, Tino JA (2004) Preparation of heterocyclic aromatic compounds useful as growth hormone secretagogues. PCT Int Appl WO 2004021984. Chem Abstr 140:270858
Zimmermann PJ, Brehm C, Palmer A, Chiesa MV, Simon W-A, Postius S, Kromer W, Buhr W (2005) Preparation of 1,2,4-triazolo[4,3-a]pyridines for the treatment of gastrointestinal disorders. PCT Int Appl WO 2005077947. Chem Abstr 143:229865
Lawson EC, Maryanoff BE, Hoekstra WJ (2000) Tetrahedron Lett 41:4533
Chang JJ, Wang Y, Zhang HZ, Zhou CH, Geng RX, Ji QG (2011) Chem J Chin Univ 32:1985 (in Chinese)
Bai X, Zhou CH, Mi JL (2007) Chem Res Appl 19:1729 (in Chinese)
Zhou CH, Wang Y (2012) Curr Med Chem 19:239
Petrikkos G, Siada A (2007) Int J Antimicrob Agents 30:108
Peng XM, Cai GX, Zhou CH (2013) Curr Top Med Chem 13:1963
Yang J, Li Q, Zhang J, Lin W, Wang J, Wang Y, Huang Z, Shi D (2013) Molecules 18:14519
Acknowledgements
We are grateful to the Research Council of the University of Sistan and Baluchestan for their support of this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shokoohian, M., Hazeri, N., Maghsoodlou, M.T. et al. Pseudo-three-component synthesis of substituted 1,2,4-triazolo[1,5-a]pyridines. Monatsh Chem 151, 93–98 (2020). https://doi.org/10.1007/s00706-019-02522-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-019-02522-3